US/UK/Canada

Share

Pick a time period -
Tags ( Active)

CIMZIA[®] (certolizumab pegol) now Available for Patients in Japan living with Multiple Psoriatic Diseases

· Approval in Japan is based on a late stage clinical trial, which confirmed the efficacy, safety, and durability of response with CIMZIA in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma · This milestone marks the continued expansion of CIMZIA in important markets and reinforces UCB’s commitment in dermatologyBrussels, Belgium – 28 January, 07:00 CET – UCB announced today that it received approval from Japanese health authorities for CIMZIA[®] (certolizumab pegol) to treat plaque psoriasis, psoriatic arthritis, pustular

Disposal of own shares

Brussels (Belgium), 27 January 2020 – 20:00 (CET) – regulated information In application of article 8:6 of the Royal Decree executing the new Belgian Code of Companies and Associations, UCB SA/NV announces that following exercises of stock options by its employees, it has disposed of UCB shares OTC in view of deliveries of shares to the relevant employees, within the framework of the Long Term Incentive Program of the UCB Group, as follows:    This press release is available on UCB SA/NV’s website via the following link 

Transparency notification UCB SA/NV

· Notification referring to situation on 17 January 2020 · Threshold crossed: 3% · Latest holding: 2.95%Brussels (Belgium), 20 January 2020 – 20:10 (CET) – regulated information 1.  Summary of the notification Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has filed a transparency notification. The transparency notification dated 20 January 2020 has been submitted in accordance with Article 18 juncto Article 6 of the law of 2 May 2007 on the disclosure of large shareholdings, due to UCB covering its

Disposal of own shares

Brussels (Belgium), 20 January 2020 – 20:05 (CET) – regulated information In application of article 8:6 of the Royal Decree executing the new Belgian Code of Companies and Associations, UCB SA/NV announces that following exercises of stock options by its employees, it has disposed of UCB shares OTC in view of deliveries of shares to the relevant employees, within the framework of the Long Term Incentive Program of the UCB Group, as follows: This press release is available on UCB SA/NV’s website via the following link 

Transparency notification BlackRock, Inc.

· Notification referring to situation on 13 January 2020 · Threshold crossed: 5% · Latest holding: 4.91%Brussels (Belgium), 20 January 2020 – 20:00 (CET) – regulated information 1.  Summary of the notification Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification from BlackRock, Inc. (having its registered office at 55 East 52nd Street, New York, NY, 10055, U.S.A.), dated 14 January 2020. BlackRock, Inc. has notified that, following a disposal of UCB shares with voting

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe